SCHEMBL6787809

SCHEMBL6787809

Cc1cc([N+](=O)[O-])ccc1N(C)CCc1ccccn1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.65
PIK3CD O00329 1/20 0.47
PIK3R1 P27986 1/20 0.47
PIK3CB P42338 1/20 0.47
PKM P14618 1/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
KDM4E B2RXH2 2/20 0.45
TSHR P16473 1/20 0.45
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6794648 0.87 POLB (0.64) POLBPIK3CDPIK3R1PIK3CBPKM
SCHEMBL6792835 0.85 POLB (0.53) POLBPIK3CDPIK3R1PIK3CBPKM
SCHEMBL6795581 0.81 POLB (0.73) POLBPKMALDH1A1KMT2AMEN1
SCHEMBL6794650 0.79 POLB (1.00) POLBPIK3CDPIK3R1PIK3CBPKM
SCHEMBL21590213 0.76 ALDH1A1 (0.55) POLBPIK3CDPIK3R1PIK3CBALDH1A1
SCHEMBL4029429 0.76 TP53 (0.47) POLBALDH1A1KMT2AMEN1NPC1
SCHEMBL4844382 0.75 ALDH1A1 (0.70) POLBPKMALDH1A1KMT2AMEN1
SCHEMBL3151107 0.74 KDM4E (0.67) POLBALDH1A1KMT2ACYP2D6CYP2C9
SCHEMBL9446990 0.74 CYP2D6 (0.66) POLBALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL6252749 0.74 POLB (0.50) POLBPIK3CDPIK3R1PIK3CBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed
CN-1478077-A Benzamide compounds as APO B secretion inhibitors ����ҩƷ��ҵ��ʽ���� 2004-02-25 CN disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 POLB 1470/4885PIK3CD 3852/4885PIK3R1 4140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.